Agios Pharma (AGIO) Tops Q2 EPS by 5c

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.51), $0.05 better than the analyst estimate of ($1.56). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $6.54 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy
• Agios Pharma (AGIO) PT Raised to $54 at H.C. Wainwright